ArticleLeukemia2014

A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.

H Eda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.